Search - tctmd.com

Displaying 661 - 680 of 1183

Sort: Relevancy | Date

Presentation TCT 2018

Noninvasive Monitoring With Sensible Medical for Preventing Heart Failure Rehospitalizations

Presenter: Stefan Anker, Ileana L. Pina, Daniel R. Bensimhon

September 22, 2018

Presentation TCT 2018

Endotronix: Differentiating Features and Results

Presenter: Stefan Anker, Ileana L. Pina, Katrin Leadley

September 22, 2018

Presentation TCT 2018

Cardiomems: Update and Ongoing Studies

Presenter: Stefan Anker, Ileana L. Pina, JoAnn Lindenfeld

September 22, 2018

Presentation TCT 2018

State-of-the-Art: Invasive and Noninvasive Technologies for Monitoring Congestion

Presenter: Stefan Anker, Ileana L. Pina, William T. Abraham

September 22, 2018

Presentation TCT 2018

State-of-the-Art: Congestion and Prognosis in HF

Presenter: Stefan Anker, Ileana L. Pina, Peter Carson

September 22, 2018

Presentation TCT 2018

Treatment of LV Aneurysms: Revivent

Presenter: James E. Udelson, Clyde W. Yancy, Horst Sievert

September 22, 2018

Presentation TCT 2018

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

Presenter: Michael J. Mack, Bernard Prendergast, George D. Dangas

September 22, 2018

Presentation TCT 2018

Percutaneous Ventricular Reshaping of the LV for Chronic Heart Failure: Ancora

Presenter: James E. Udelson, Clyde W. Yancy, Daniel Burkhoff

September 22, 2018

Presentation TCT 2018

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

Presenter: Michael J. Mack, Bernard Prendergast, Davide Capodanno

September 22, 2018

Presentation TCT 2018

Aortic Arch Neuromodulation for Chronic Heart Failure: EnoPace

Presenter: James E. Udelson, Clyde W. Yancy, Felix Mahfoud

September 22, 2018

Presentation TCT 2018

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Presenter: Michael J. Mack, Bernard Prendergast, Lars Sondergaard

September 22, 2018

Presentation TCT 2018

Cardiac Contractility Modulation for HFrEF and HFmrEF

Presenter: James E. Udelson, Clyde W. Yancy, William T. Abraham

September 22, 2018

Presentation TCT 2018

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

Presenter: Michael J. Mack, Bernard Prendergast, Adam B. Greenbaum

September 22, 2018

Presentation TCT 2018

Interatrial Shunts II: V-wave

Presenter: James E. Udelson, Clyde W. Yancy, JoAnn Lindenfeld

September 22, 2018

Presentation TCT 2018

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

Presenter: Michael J. Mack, Bernard Prendergast, Adnan K. Chhatriwalla

September 22, 2018

Presentation TCT 2018

Interatrial Shunts I: Corvia

Presenter: James E. Udelson, Clyde W. Yancy, Ted Feldman

September 22, 2018

Presentation TCT 2018

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Presenter: Michael J. Mack, Bernard Prendergast, Philipp Blanke

September 22, 2018

Presentation TCT 2018

Clinical Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes

Presenter: Michael J. Mack, Bernard Prendergast, John G. Webb

September 22, 2018

Presentation TCT 2018

TAVR in Heart Failure: UNLOAD

Presenter: James E. Udelson, Clyde W. Yancy, Ori Ben-Yehuda

September 22, 2018

Presentation TCT 2018

Status Update of the TAVR UNLOAD Trial Moderate AS Patients with Reduced Ejection Fraction and Heart Failure

Presenter: Allan Schwartz, Stephan Windecker, Joost Daemen

September 22, 2018

Advertisement

Noninvasive Monitoring With Sensible Medical for Preventing Heart Failure Rehospitalizations

Endotronix: Differentiating Features and Results

Cardiomems: Update and Ongoing Studies

State-of-the-Art: Invasive and Noninvasive Technologies for Monitoring Congestion

State-of-the-Art: Congestion and Prognosis in HF

Treatment of LV Aneurysms: Revivent

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

Percutaneous Ventricular Reshaping of the LV for Chronic Heart Failure: Ancora

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

Aortic Arch Neuromodulation for Chronic Heart Failure: EnoPace

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Cardiac Contractility Modulation for HFrEF and HFmrEF

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

Interatrial Shunts II: V-wave

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

Interatrial Shunts I: Corvia

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Clinical Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes

TAVR in Heart Failure: UNLOAD

Status Update of the TAVR UNLOAD Trial Moderate AS Patients with Reduced Ejection Fraction and Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content